Clinical Trials: Find a Clinical Trial

At any time Memorial Sloan Kettering Cancer Center is conducting hundreds of clinical trials to improve care for many types of cancer. Use the tool below to browse our clinical trials that are currently enrolling new patients. Each listing explains the purpose of the trial, the trial’s eligibility criteria, and how to get more information.

The list below includes clinical trials for adult cancers. Please visit our pediatric cancer care section to find a pediatric clinical trial.

Showing 321 - 340 of 490 trials
Title Investigatorsort icon Disease(s)
A Phase II Study of Radioactive Iodine with and without Selumetinib in Patients with High-Risk Thyroid Cancer After Thyroidectomy
[Protocol 13-133]
Ho, Alan
  • Thyroid Cancer
A Phase I Study of LY2940680 in Patients with Advanced Basal Cell Skin Cancer
[Protocol 13-005]
Ho, Alan
  • Basal Cell Carcinoma
A Phase II Study of Regorafenib in Patients with Recurrent or Metastatic Adenoid Cystic Carcinoma
[Protocol 13-244]
Ho, Alan
  • Head & Neck Cancer
A Phase III Study of Gemcitabine, Docetaxel, and Doxorubicin versus Observation in Women with High-Grade Uterine Leiomyosarcoma
[Protocol 12-177]
Hensley, Martee
  • Uterine Sarcoma
    • Leiomyosarcoma
A Study Assessing Patients' Quality of Life and Function after Different Types of Surgery for Cancer in the Femur (Thighbone)
Relapsed/Refractory
[Protocol 12-287]
Healey, John
  • Primary Bone
  • Solid Tumors
An Evaluation of Perceptions and Quality of Life Among Patients Receiving Ipilimumab for Melanoma
[Protocol 11-184]
Hay, Jennifer
  • Melanoma
  • Quality of Life
A Phase II Study of Bortezomib/Dexamethasone Followed by Lenalidomide in Nonresponders as Initial Treatment for Multiple Myeloma
[Protocol 13-064]
Hassoun, Hani
  • Hematology
    • Multiple Myeloma
A Pilot Study of Bortezomib/Dexamethasone Followed by Autologous Stem Cell Transplantation and Maintenance Bortezomib/Dexamethasone for the Initial Treatment of MIDD Associated with Multiple Myeloma and Amyloidosis
Newly Diagnosed
[Protocol 11-061]
Hassoun, Hani
  • Hematology
    • Hematologic Disorders
    • Hematologic Malignancies
    • Multiple Myeloma
A Phase I/II Study of Pomalidomide and Dexamethasone with and without Ixazomib in Patients with Recurrent Multiple Myeloma
[Protocol 14-055]
Hassoun, Hani
  • Hematology
    • Multiple Myeloma
A Phase III Study of Lenalidomide, Bortezomib, and Dexamethasone Combination Treatment with or without Peripheral Stem Cell Transplantation in the Initial Management of Multiple Myeloma
Newly Diagnosed
[Protocol 12-018]
Hassoun, Hani
  • Hematology
    • Multiple Myeloma
A Phase II Study of Lenalidomide Intensification in Patients with Asymptomatic Multiple Myeloma that Has Progressed with Lenalidomide Maintenance Therapy after Autologous Stem Cell Transplantation
Newly Diagnosed
[Protocol 11-107]
Hassoun, Hani
  • Hematology
    • Multiple Myeloma
A Phase Ib Study of Ramucirumab plus LY2875358 in Patients with Advanced Cancer
[Protocol 14-049]
Harding, James
  • Solid Tumors
A Phase III Study of Bendamustine and Rituximab with or without Ibrutinib in Older Patients with Newly Diagnosed Mantle Cell Lymphoma
[Protocol 13-196]
Hamlin, Paul
  • Lymphoma
    • Non-Hodgkin's Lymphoma
Ofatumumab with or without Bendamustine for Patients with Mantle Cell Lymphoma Who Cannot Have an Autologous Stem Cell Transplant
Newly Diagnosed
[Protocol 11-050]
Hamlin, Paul
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase III Study of Ibritumomab Tiuxetan versus Observation in Older Patients with Diffuse Large B-Cell Lymphoma in Remission following R-CHOP
Newly Diagnosed
[Protocol 12-061]
Hamlin, Paul
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Comprehensive Assessment to Predict Side Effects from Chemotherapy and an Evaluation of Pre-Phase Chemotherapy in Older Patients with Non-Hodgkin Lymphoma
[Protocol 13-028]
Hamlin, Paul
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase I Study of PRT062070 in Patients with Persistent or Recurrent Chronic Lymphocytic Leukemia, Small Cell Lymphocytic Leukemia, or B-Cell Non-Hodgkin Lymphoma
[Protocol 14-023]
Hamlin, Paul
  • Leukemia
    • Chronic Lymphocytic Leukemia
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase II Study of Brentuximab (SGN-35) Given Before and After Adriamycin, Vinblastine, and Dacarbazine Therapy in Older Adults with Untreated Hodgkin Lymphoma
[Protocol 11-201]
Hamlin, Paul
  • Lymphoma
    • Hodgkin's Disease
Hereditary Colorectal Cancer Family Registry
[Protocol 01-110]
Guillem, Jose
  • Colorectal Cancer
  • Hereditary Cancer & Genetics
A Phase I Study of Pomalidomide in Patients with Recurrent or Persistent Primary Central Nervous System Lymphoma or Primary Vitreoretinal Lymphoma
Relapsed/Refractory
[Protocol 14-003]
Grommes, Christian
  • Brain Tumors, Primary
    • Primary Central Nervous System Lymphoma
  • Lymphoma